EMBO Installation Grants: 11 winners announced
17 January 2023 - EMBO is delighted to announce 11 winners of the 2023 EMBO Installation Grants, which provide multi-year funding for principal investigators to establish and grow their groups in participating countries.
The new Installation Grantees will set up their laboratories in seven countries: Croatia, the Czech Republic, Estonia, Lithuania, Poland, Portugal, and Türkiye (Turkey). Research projects will cover themes as diverse as cancer biology, viral dynamics, gene editing technologies, and the role of phytoplankton in the global carbon cycle.
“EMBO Installation Grants provide a tremendous opportunity for researchers to embark on a wide-range of ambitious life science projects,” says EMBO Director Fiona Watt. “The programme supports group leaders in founding and growing their labs, provides mentoring, networking and training opportunities, and also helps build vibrant, interdisciplinary national and international research communities.”
Each group leader receives 50,000 euros annually for three to five years and can also apply for additional grants of up to 10,000 euros per year. Grantees become part of the EMBO Young Investigator Network, which consists of more than 600 current and former EMBO Young Investigators, Installation Grantees and Global Investigators. Benefits include networking, mentoring, and training opportunities, as well as access to core facilities at the European Molecular Biology Laboratory (EMBL) in Heidelberg, Germany.
35,000 euros of the annual payments are provided by funding agencies or ministries in each participating country, and 15,000 euros are provided by EMBC (European Molecular Biology Conference), the EMBO funding body.
This year’s grants are supported by the Ministry of Science and Education of Croatia; the Ministry of Education, Youth and Sports of the Czech Republic; the Ministry of Science and Education of Croatia, the Estonian Research Council; Research Council of Lithuania; the Ministry of Science and Higher Education of Poland; the Champalimaud Foundation, the Instituto Gulbenkian de Ciência and the Foundation for Science and Technology of Portugal; and the Scientific and Technological Research Council (TÜBITAK) of Türkiye.
The new EMBO Installation Grantees will establish laboratories in different European countries. One laboratory will be in Croatia, one in the Czech Republic, one in Estonia, two in Lithuania, two in Poland, two in Portugal, and two in Türkiye. Six of the 11 grantees are female (55%) and five are male (45%). All have spent at least two consecutive years outside the country in which they are setting up their laboratory in the four years preceding their application.
The next application deadline is 15 April 2023. More information on EMBO Installation Grants, including eligibility criteria and the application process, is available here.
Name Project title Host insitute
Adam Klosin Spatial organisation of transcription in embryonic development Nencki Institute, Warsaw, PL
Ana Luisa Correia Tissue-specific immune regulation of disseminated tumour cell dormancy Champalimaud Foundation, Lisbon, PT
Unveiling the mechanisms of brain endothelial dysfunction with chemogenetics Medipol University, Istanbul, TR
Gytis Dudas Characterising metagenomically discovered orthomyxovirus surface proteins Vilnius University, Vilnius, LT
Hedvig Tamman The role of stringent response in the phage defence of Pseudomonas putida Tartu University, Tartu, EE
Jelena Godrijan Decoding the influence of coccolithophore life cycle on the oceanic carbon cycle Ruđer Bošković Institute, Zagreb, HR
Marco Fumasoni Evolutionary rewiring genome maintenance Instituto Gulbenkian de Ciência, Oeiras, PT
Michaela Fenckova Drosophila habituation for preclinical research of neurodevelopmental disorders University of South Bohemia, České Budějovice, CZ
GBM-shuttle: glioblastoma blood-brain barrier model for developing nano-shuttles Sabancı University, Istanbul, TR
Patrick Pausch Mobile genetic elements as a source of new genome editing technology Vilnius University, Vilnius, LT
Urszula McClurg How is the germ-soma barrier maintained and why does it often fail in cancer?